Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fraction
Article in PLOS ONE (August 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Influenza vaccination for heart failure patients: a cost-effectiveness analysis from the perspective of Chinese healthcare system
Article in Frontiers in Public Health (August 2024)
Cost–Utility Analysis of Vericiguat in Heart Failure with Reduced Ejection Fraction After Worsening Heart Failure Events in China
Article in American Journal of Cardiovascular Drugs (April 2024)